Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835Open textbooks209Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›Open textbooks›Nurse-delivered sleep restriction therapy to improve insomnia disorder in primary care: the HABIT RCT›References

Continue where you left off ()

Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Nurse-delivered sleep restriction therapy to improve insomnia disorder in primary care: the HABIT RCT · References

References

CC BY 4.0 · National Institute for Health and Care Research · approximately 13 min read

  1. Kyle SD, Madigan C, Begum N, Abel L, Armstrong S, Aveyard P, et al. Primary care treatment of insomnia: study protocol for a pragmatic, multicentre, randomised controlled trial comparing nurse-delivered sleep restriction therapy to sleep hygiene (the HABIT trial). BMJ Open 2020;10:e036248. 10.1136/bmjopen-2019-036248
  2. Kyle SD, Espie CA, Morgan K. ‘… Not just a minor thing, it is something major, which stops you from functioning daily’: quality of life and daytime functioning in insomnia. Behav Sleep Med 2010;8:123–40. 10.1080/15402002.2010.48745020582756
  3. Kyle SD, Crawford MR, Morgan K, Spiegelhalder K, Clark AA, Espie CA. The Glasgow Sleep Impact Index (GSII): a novel patient-centred measure for assessing sleep-related quality of life impairment in insomnia disorder. Sleep Med 2013;14:493–501. 10.1016/j.sleep.2012.10.02323347908
  4. Morin CM, Benca R. Chronic insomnia. Lancet 2012;379:1129–41. 10.1016/S0140-6736(11)60750-222265700
  5. Vgontzas AN, Fernandez-Mendoza J, Liao D, Bixler EO. Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med Rev 2013;17:241–54. 10.1016/j.smrv.2012.09.00523419741
  6. Taddei-Allen P. Economic burden and managed care considerations for the treatment of insomnia. Am J Manag Care 2020;26:S91–6. 10.37765/ajmc.2020.4300832282179
  7. Wickwire EM, Tom SE, Scharf SM, Vadlamani A, Bulatao IG, Albrecht JS. Untreated insomnia increases all-cause health care utilization and costs among Medicare beneficiaries. Sleep 2019;42:zsz007. 10.1093/sleep/zsz00730649500
  8. Wickwire EM, Shaya FT, Scharf SM. Health economics of insomnia treatments: the return on investment for a good night’s sleep. Sleep Med Rev 2016;30:72–82. 10.1016/j.smrv.2015.11.00426874067
  9. Daley M, Morin CM, LeBlanc M, Grégoire JP, Savard J. The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep 2009;32:55–64. 10.5665/sleep/32.1.5519189779
  10. Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD; Clinical Guidelines Committee of the American College of Physicians. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2016;165:125–33. 10.7326/M15-217527136449
  11. Riemann D, Baglioni C, Bassetti C, Bjorvatn B, Dolenc Groselj L, Ellis JG, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res 2017;26:675–700. 10.1111/jsr.1259428875581
  12. National Institute for Health and Care Excellence (NICE). CKS is Only Available in the UK. URL: http://cks.nice.org.uk/insomnia#!scenario:1 (accessed March 2022).
  13. Wilson S, Anderson K, Baldwin D, Dijk DJ, Espie A, Espie C, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update. J Psychopharmacol 2019;33:923–47. 10.1177/026988111985534331271339
  14. Everitt H, McDermott L, Leydon G, Yules H, Baldwin D, Little P. GPs’ management strategies for patients with insomnia: a survey and qualitative interview study. Br J Gen Pract 2014;64:e112–9. 10.1016/j.smrv.2018.09.00424567616
  15. Dyas JV, Apekey TA, Tilling M, Ørner R, Middleton H, Siriwardena AN. Patients’ and clinicians’ experiences of consultations in primary care for sleep problems and insomnia: a focus group study. Br J Gen Pract 2010;60:e180–200. 10.3399/bjgp10X48418320423574
  16. Maire M, Linder S, Dvorak C, Merlo C, Essig S, Tal K, et al. Prevalence and management of chronic insomnia in Swiss primary care: cross-sectional data from the ‘Sentinella’ practice-based research network. J Sleep Res 2020;29:e13121. 10.1111/jsr.1312132588519
  17. Buysse DJ, Germain A, Moul DE, Franzen PL, Brar LK, Fletcher ME, et al. Efficacy of brief behavioral treatment for chronic insomnia in older adults. Arch Intern Med 2011;171:887–95. 10.1001/archinternmed.2010.53521263078
  18. Espie CA, Inglis SJ, Tessier S, Harvey L. The clinical effectiveness of cognitive behaviour therapy for chronic insomnia: implementation and evaluation of a sleep clinic in general medical practice. Behav Res Ther 2001;39:45–60. 10.1016/s0005-7967(99)00157-611125723
  19. Espie CA, MacMahon KM, Kelly HL, Broomfield NM, Douglas NJ, Engleman HM, et al. Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice. Sleep 2007;30:574–84. 10.1093/sleep/30.5.57417552372
  20. Espie CA, Fleming L, Cassidy J, Samuel L, Taylor LM, White CA, et al. Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol 2008;26:4651–8. 10.1200/jco.2007.13.900618591549
  21. Cheung JMY, Jarrin DC, Ballot O, Bharwani A, Morin CM. A systematic review of adaptive cognitive behavioral therapy for insomnia implemented in primary care settings. Sleep Med 2017;40:e59. 10.1016/j.sleep.2017.11.165
  22. Davidson J, Dickson C, Han H. Cognitive behavioural treatment for insomnia in primary care: a systematic review of sleep outcomes. Br J Gen Pract 2019;69:e657–64. 10.3399/bjgp19X70506531358494
  23. Maurer LF, Espie CA, Kyle SD. How does sleep restriction therapy for insomnia work? A systematic review of mechanistic evidence and the introduction of the Triple-R model. Sleep Med Rev 2018;42:127–38. 10.1016/j.jad.2017.04.00330177248
  24. Maurer LF, Ftouni S, Espie CA, Bisdounis L, Kyle SD. The acute effects of sleep restriction therapy for insomnia on circadian timing and vigilance. J Sleep Res 2021;30:e13260. 10.1111/jsr.1326033314496
  25. Maurer LF, Espie CA, Omlin X, Kyle SD. The effect of sleep restriction therapy for insomnia on multidimensional assessments of sleep pressure and arousal: results from a randomised, controlled, mechanistic trial. Sleep 2022;45:zsab223. 10.1093/sleep/zsab22334463762
  26. Maurer LF, Espie CA, Omlin X, Reid MJ, Sharman R, Gavriloff D, et al. Isolating the role of time in bed restriction in the treatment of insomnia: a randomized, controlled, dismantling trial comparing sleep restriction therapy with time in bed regularization. Sleep 2020;43:zsaa096. 10.1093/sleep/zsaa09632421814
  27. Maurer LF, Schneider J, Miller CB, Espie CA, Kyle SD. The clinical effects of sleep restriction therapy for insomnia: a meta-analysis of randomised controlled trials. Sleep Med Rev 2021;58:101493. 10.1016/j.smrv.2021.10149333984745
  28. Falloon K, Elley CR, Fernando A, 3rd, Lee AC, Arroll B. Simplified sleep restriction for insomnia in general practice: a randomised controlled trial. Br J Gen Pract 2015;65:e508–15. 10.3399/bjgp15X68613726212846
  29. Kyle SD, Morgan K, Spiegelhalder K, Espie CA. No pain, no gain: an exploratory within-subjects mixed-methods evaluation of the patient experience of sleep restriction therapy (SRT) for insomnia. Sleep Med 2011;12:735–47. 10.1016/j.sleep.2011.03.01621907616
  30. Sargent GM, Forrest LE, Parker RM. Nurse delivered lifestyle interventions in primary health care to treat chronic disease risk factors associated with obesity: a systematic review. Obes Rev 2012;13:1148–71. 10.1111/j.1467-789X.2012.01029.x22973970
  31. Morgan K, Dixon S, Mathers N, Thompson J, Tomeny M. Psychological treatment for insomnia in the management of long-term hypnotic drug use: a pragmatic randomised controlled trial. Br J Gen Pract 2003;53:923.14960215
  32. Morgan K, Gregory P, Tomeny M, David BM, Gascoigne C. Self-help treatment for insomnia symptoms associated with chronic conditions in older adults: a randomized controlled trial. J Am Geriatr Soc 2012;60:1803–10. 10.1111/j.1532-5415.2012.04175.x23035962
  33. Natsky AN, Vakulin A, Chai-Coetzer CL, Lack L, McEvoy RD, Kaambwa B. Economic evaluation of cognitive behavioural therapy for insomnia (CBT-I) for improving health outcomes in adult population: a systematic review. Sleep Med Rev 2020;54:101351. 10.1016/j.smrv.2020.10135132739824
  34. Espie CA, Kyle SD, Hames P, Gardani M, Fleming L, Cape J. The Sleep Condition Indicator: a clinical screening tool to evaluate insomnia disorder. BMJ Open 2014;4:e004183. 10.1136/bmjopen-2013-004183
  35. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th edn. Arlington, VA: Author; 2013.
  36. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193–213. 10.1016/0165-1781(89)90047-42748771
  37. Wilson SJ, Nutt DJ, Alford C, Argyropoulos SV, Baldwin DS, Bateson AN, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol 2010;24:1577–601. 10.1177/026988111037930720813762
  38. Edinger JD, Arnedt JT, Bertisch SM, Carney CE, Harrington JJ, Lichstein KL, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med 2021;17:263–98. 10.5664/jcsm.898833164741
  39. Espie CA, Emsley R, Kyle SD, Gordon C, Drake CL, Siriwardena AN, et al. Effect of digital cognitive behavioral therapy for insomnia on health, psychological well-being, and sleep-related quality of life: a randomized clinical trial. JAMA Psychiatry 2019;76:21–30. 10.1001/jamapsychiatry.2018.274530264137
  40. Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001;2:297–307. 10.1016/S1389-9457(00)00065-411438246
  41. Morin CM, Belleville G, Bélanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep 2011;34:601–8. 10.1093/sleep/34.5.60121532953
  42. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473–83.1593914
  43. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9. J Gen Intern Med 2001;16:606–13. 10.1046/j.1525-1497.2001.016009606.x11556941
  44. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics 1993;4:353–65. 10.2165/00019053-199304050-0000610146874
  45. Nicassio PM, Mendlowitz DR, Fussell JJ, Petras L. The phenomenology of the pre-sleep state: the development of the pre-sleep arousal scale. Behav Res Ther 1985;23:263–71. 10.1016/0005-7967(85)90004-X4004706
  46. Broomfield NM, Espie CA. Towards a valid, reliable measure of sleep effort. J Sleep Res 2005;14:401–7. 10.1111/j.1365-2869.2005.00481.x16364141
  47. Carney CE, Buysse DJ, Ancoli-Israel S, Edinger JD, Krystal AD, Lichstein KL, Morin CM. The consensus sleep diary: standardizing prospective sleep self-monitoring. Sleep 2012;35:287–302. 10.5665/sleep.164222294820
  48. Beecham J, Knapp M. Costing psychiatric interventions. In Measuring Mental Health Needs. London: Gaskell/Royal College of Psychiatrists; 1992. pp. 163–83.
  49. Rabin R, Charro F. EQ-SD: a measure of health status from the EuroQol Group. Ann Med 2001;33:337–43. 10.3109/0785389010900208711491192
  50. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21:271–92. 10.1016/S0167-6296(01)00130-811939242
  51. Yang Y, Brazier J, Tsuchiya A. Effect of adding a sleep dimension to the EQ-5D descriptive system: a ‘bolt-on’ experiment. Med Decis Making 2013;34:42–53. 10.1177/0272989X1348042823525702
  52. Dyas JV, Togher F, Siriwardena AN. Intervention fidelity in primary care complex intervention trials: qualitative study using telephone interviews of patients and practitioners. Qual Prim Care 2014;22:25–34.24589148
  53. Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods 2006;18:59–82.
  54. Adan A, Almirall H. Horne & Östberg morningness-eveningness questionnaire: a reduced scale. Pers Individ Dif 1991;12:241–53. 10.1016/0191-8869(91)90110-W
  55. Baron RM, Kenny DA. The moderator–mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173. 10.1037//0022-3514.51.6.11733806354
  56. Freeman D, Sheaves B, Goodwin GM, Yu LM, Nickless A, Harrison PJ, et al. The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysis. Lancet Psychiatry. 2017 Oct;4:749–58. 10.1016/S2215-0366(17)30328-0. Epub 2017 Sep 6.28888927
  57. Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ 2015;350:h1258. 10.1136/bmj.h125825791983
  58. Jenkinson C, Stewart-Brown S, Petersen S, Paice C. Assessment of the SF-36 version 2 in the United Kingdom. J Epidemiol Community Health 1999;53:46. 10.1136/jech.53.1.4610326053
  59. Petrou S, Gray A. Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting. BMJ 2011;342:d1548. 10.1136/bmj.d154821474510
  60. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al.; CHEERS Task Force. Consolidated health economic evaluation reporting standards (cheers) statement. Int J Technol Assess Health Care 2013;29:117–22. 10.1017/S026646231300016023587340
  61. NHS Improvement. Archived Reference Costs. URL: https://improvement.nhs.uk/resources/reference-costs/ (accessed March 2022).
  62. Curtis L, Burns A. Unit Costs of Health and Social Care 2018. Personal Social Services Research Unit. Canterbury: University of Kent. 10.22024/UniKent/01.02.70995
  63. National Institute for Health and Care Excellence (NICE). British National Formulary. URL: https://bnfc.nice.org.uk/ (accessed March 2022).
  64. National Institute for Health and Care Excellence (NICE). Guide to the Methods of Technology Appraisal 2013. URL: www.nice.org.uk/process/pmg9/chapter/foreword (accessed March 2022).
  65. Faria R, Gomes M, Epstein D, White IR. A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials. PharmacoEconomics 2014;32:1157–70. 10.1007/s40273-014-0193-325069632
  66. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011;30:377–99. 10.1002/sim.406721225900
  67. Schomaker M, Heumann C. Bootstrap inference when using multiple imputation. Stat Med 2018;37:2252–66. 10.1002/sim.765429682776
  68. Irvine A, Drew P, Bower P, Brooks H, Gellatly J, Armitage CJ, et al. Are there interactional differences between telephone and face-to-face psychological therapy? A systematic review of comparative studies. J Affect Disord 2020;265:120–31. 10.1016/j.jad.2020.01.05732090733
  69. Miller CB, Kyle SD, Marshall NS, Espie CA. Ecological momentary assessment of daytime symptoms during sleep restriction therapy for insomnia. J Sleep Res 2013;22:266–72. 10.1111/jsr.1202423331712
  70. Kyle SD, Miller CB, Rogers Z, Siriwardena AN, Macmahon KM, Espie CA. Sleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively impaired vigilance: implications for the clinical management of insomnia disorder. Sleep 2014;37:229–37. 10.5665/sleep.338624497651
  71. van der Zweerde T, Bisdounis L, Kyle SD, Lancee J, van Straten A. Cognitive behavioral therapy for insomnia: a meta-analysis of long-term effects in controlled studies. Sleep Med Rev 2019;48:101208. 10.1016/j.smrv.2019.08.00231491656
  72. Van Straten A, Van der Zweerde T, Kleiboer A, Cuijpers P, Morin CM, Lancee J. Cognitive and behavioral therapies in the treatment of insomnia: a meta-analysis. Sleep Med Rev 2018;38:3–16. 10.1016/j.smrv.2017.02.00128392168
  73. Mitchell LJ, Bisdounis L, Ballesio A, Omlin X, Kyle SD. The impact of cognitive behavioural therapy for insomnia on objective sleep parameters: a meta-analysis and systematic review. Sleep Med Rev 2019;47:90–102. 10.1016/j.smrv.2019.06.00231377503
  74. Benz F, Knoop T, Ballesio A, Bacaro V, Johann AF, Rücker G, et al. The efficacy of cognitive and behavior therapies for insomnia on daytime symptoms: a systematic review and network meta-analysis. Clin Psychol Rev 2020;80:101873. 10.1016/j.cpr.2020.101873:10187332777632
  75. Morin CM, LeBlanc M, Daley M, Gregoire JP, Mérette C. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med 2006;7:123–30. 10.1016/j.sleep.2005.08.00816459140
  76. Hertenstein E, Feige B, Gmeiner T, Kienzler C, Spiegelhalder K, Johann A, et al. Insomnia as a predictor of mental disorders: a systematic review and meta-analysis. Sleep Med Rev 2019;43:96–105. 10.1016/j.smrv.2018.10.00630537570
  77. Santoft F, Axelsson E, Öst LG, Hedman-Lagerlöf M, Fust J, Hedman-Lagerlöf E. Cognitive behaviour therapy for depression in primary care: systematic review and meta-analysis. Psychol Med 2019;49:1266–74. 10.1017/s003329171800420830688184
  78. Sweetman A, Putland S, Lack L, McEvoy RD, Adams R, Grunstein R, et al. The effect of cognitive behavioural therapy for insomnia on sedative-hypnotic use: a narrative review. Sleep Med Rev 2020;56:101404. 10.1016/j.smrv.2020.10140433370637
  79. Condon H, Maurer L, Kyle S. Reporting of adverse events in cognitive behavioural therapy for insomnia: a systematic examination of randomised controlled trials. Sleep Med Rev 2021;56:101412. 10.1016/j.smrv.2020.10141233422935
  80. Kaldo V, Jernelöv S, Blom K, Ljótsson B, Brodin M, Jörgensen M, et al. Guided internet cognitive behavioral therapy for insomnia compared to a control treatment – a randomized trial. Behav Res Ther 2015;71:90–100. 10.1016/j.brat.2015.06.00126091917
  81. Krieger T, Urech A, Duss SB, Blattler L, Schmitt W, Gast H, et al. A randomized controlled trial comparing guided internet-based multi-component treatment and internet-based guided sleep restriction treatment to care as usual in insomnia. Sleep Med 2019;62:43–52. 10.1016/j.sleep.2019.01.04531541851
  82. Chan C, West S, Glozier N. Commencing and persisting with a web-based cognitive behavioral intervention for insomnia: a qualitative study of treatment completers. J Med Internet Res 2017;19:e37. 10.2196/jmir.563928188124
  83. Vincent N, Lewycky S, Finnegan H. Barriers to engagement in sleep restriction and stimulus control in chronic insomnia. J Consult Clin Psychol 2008;76:820. 10.1037/0022-006X.76.5.82018837599
  84. Souman JL, Tinga AM, te Pas SF, van Ee R, Vlaskamp BNS. Acute alerting effects of light: a systematic literature review. Behav Brain Res 2018;337:228–39. 10.1016/j.bbr.2017.09.01628912014
  85. Chellappa SL, Steiner R, Blattner P, Oelhafen P, Götz T, Cajochen C. Non-visual effects of light on melatonin, alertness and cognitive performance: can blue-enriched light keep us alert? PLOS ONE 2011;6:e16429. 10.1371/journal.pone.001642921298068
  86. Phipps-Nelson J, Redman JR, Dijk DJ, Rajaratnam SMW. Daytime exposure to bright light, as compared to dim light, decreases sleepiness and improves psychomotor vigilance performance. Sleep 2003;26:695–700. 10.1093/sleep/26.6.69514572122
  87. Gabel V, Maire M, Reichert CF, Chellappa SL, Schmidt C, Hommes V, et al. Dawn simulation light impacts on different cognitive domains under sleep restriction. Behav Brain Res 2015;281:258–66. 10.1016/j.bbr.2014.12.04325549858
  88. Comtet H, Geoffroy PA, Kobayashi Frisk M, Hubbard J, Robin-Choteau L, Calvel L, et al. Light therapy with boxes or glasses to counteract effects of acute sleep deprivation. Sci Rep 2019;9:18073. 10.1038/s41598-019-54311-x31792259
  89. Mellor A, Hamill K, Jenkins MM, Baucom DH, Norton PJ, Drummond SPA. Partner-assisted cognitive behavioural therapy for insomnia versus cognitive behavioural therapy for insomnia: a randomised controlled trial. Trials 2019;20:262. 10.1186/s13063-019-3334-331068225
  90. Cape J, Leibowitz J, Whittington C, Espie CA, Pilling S. Group cognitive behavioural treatment for insomnia in primary care: a randomized controlled trial. Psychol Med 2016;46:1015–25. 10.1017/S003329171500256126670823
  91. Vedaa O, Kallestad H, Scott J, Smith OR, Pallesen S, Morken G, et al. Effects of digital cognitive behavioural therapy for insomnia on insomnia severity: a large-scale randomised controlled trial. Lancet Digit Health 2020;2:e397–406. 10.1016/S2589-7500(20)30135-733328044
  92. Christensen H, Batterham PJ, Gosling JA, Ritterband LM, Griffiths KM, Thorndike FP, et al. Effectiveness of an online insomnia program (SHUTi) for prevention of depressive episodes (the GoodNight Study): a randomised controlled trial. Lancet Psychiatry 2016;3:333–41. 10.1016/S2215-0366(15)00536-226827250
  93. Stott R, Pimm J, Emsley R, Miller CB, Espie CA. Does adjunctive digital CBT for insomnia improve clinical outcomes in an improving access to psychological therapies service? Behav Res Ther 2021;144:103922. 10.1016/j.brat.2021.10392234246110
  94. Harvey AG, Bélanger L, Talbot L, Eidelman P, Beaulieu-Bonneau S, Fortier-Brochu E, et al. Comparative efficacy of behavior therapy, cognitive therapy, and cognitive behavior therapy for chronic insomnia: a randomized controlled trial. J Consult Clin Psychol 2014;82:670–83. 10.1037/a003660624865869
  95. Bonin EM, Beecham J, Swift N, Raikundalia S, Brown JS. Psycho-educational CBT-Insomnia workshops in the community. A cost-effectiveness analysis alongside a randomised controlled trial. Behav Res Ther 2014;55:40–7. 10.1016/j.brat.2014.01.00524607500
  96. Baka A, van der Zweerde T, Lancee J, Bosmans JE, van Straten A. Cost-effectiveness of guided internet-delivered cognitive behavioral therapy in comparison with care-as-usual for patients with insomnia in general practice. Behav Sleep Med 2021;20:188–203. 10.1080/15402002.2021.190170833779437
  97. Yeung K, Zhu W, McCurry SM, et al. Cost-effectiveness of telephone cognitive behavioral therapy for osteoarthritis-related insomnia. J Am Geriatr Soc 2022;70:188–99. 10.1111/jgs.1746934633061
  98. Thiart H, Ebert DD, Lehr D, Nobis S, Buntrock C, Berking M, et al. Internet-based cognitive behavioral therapy for insomnia: a health economic evaluation. Sleep 2016;39:1769–78. 10.5665/sleep.615227450686
  99. Buntrock C, Lehr D, Smit F, Horvath H, Berking M, Spiegelhalder K, et al. Guided internet-based cognitive behavioral therapy for insomnia: health-economic evaluation from the societal and public health care perspective alongside a randomized controlled trial. J Med Internet Res 2021;23:e25609. 10.2196/2560934028361
  100. Witham MD, Anderson E, Carroll C, Dark PM, Down K, Hall AS, et al.; INCLUDE Writing Group. Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process. Trials 2020;21:694. 10.1186/s13063-020-04613-732738919
  101. Baglioni C, Altena E, Bjorvatn B, Blom K, Bothelius K, Devoto A, et al. The European Academy for Cognitive Behavioural Therapy for Insomnia: an initiative of the European Insomnia Network to promote implementation and dissemination of treatment. J Sleep Res 2020;29:e12967. 10.1111/jsr.1296731856367
  102. White IR, Horton NJ, Carpenter J, Pocock SJ. Strategy for intention to treat analysis in randomised trial with missing data. BMJ 2011;342:d40. 10.1136/bmj.d4021300711
← DiscussionAdditional information →

Attribution. Simon D Kyle; Peter Bower; Ly-Mee Yu; Aloysius Niroshan Siriwardena; Yaling Yang; Stavros Petrou et al. (2024). Nurse-delivered sleep restriction therapy to improve insomnia disorder in primary care: the HABIT RCT. National Institute for Health and Care Research. Copyright © 2024 Kyle et al. Licensed under CC BY 4.0. NCBI Bookshelf NBK606284. CC BY 4.0. Original source ↗. Text reproduced from the Bookshelf XML without changing wording; figures, images and supplements are not reproduced.

In this chapter Contents

  • References

Source

OpenStax source file ↗

Source record ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support